Detalhe da pesquisa
1.
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination.
Blood
; 139(5): 678-685, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861036
2.
Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions.
Hematol Oncol
; 42(1): e3238, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37937506
3.
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Haematologica
; 107(3): 625-634, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320789
4.
Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia.
Hematol Oncol
; 40(3): 313-319, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304771
5.
A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents.
Hematol Oncol
; 39(5): 595-604, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596261
6.
Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen.
Hematol Oncol
; 39(1): 129-133, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038272
7.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
8.
Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on.
Hematol Oncol
; 38(2): 129-136, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732977
9.
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Hematol Oncol
; 38(4): 439-445, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495944
10.
Bone lesions in hairy cell leukemia: Diagnosis and treatment.
Eur J Haematol
; 105(6): 682-691, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757401
11.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Blood
; 129(5): 553-560, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903528
12.
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.
Hematol Oncol
; 37(2): 185-192, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756414
13.
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.
Eur J Haematol
; 103(4): 335-341, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278876
14.
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
N Engl J Med
; 373(25): 2425-37, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26639149
15.
Discordant bone marrow involvement in non-Hodgkin lymphoma.
Blood
; 127(8): 965-70, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679865
16.
Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome.
Hematol Oncol
; 36(5): 733-739, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29862535
17.
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma.
Hematol Oncol
; 36(1): 349-354, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28156016
18.
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.
Hematol Oncol
; 36(1): 128-135, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639416
19.
The net clinical benefit of targeted agents in the upfront treatment of elderly/unfit chronic lymphocytic leukemia patients: Results of network meta-analysis.
Eur J Haematol
; 110(6): 774-777, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786335
20.
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
Eur J Haematol
; 101(3): 399-406, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29949186